Ignite Creation Date:
2024-05-06 @ 3:20 AM
Last Modification Date:
2024-10-26 @ 11:32 AM
Study NCT ID:
NCT02268799
Status:
COMPLETED
Last Update Posted:
2015-08-13
First Post:
2014-10-15
Brief Title:
High Sensitivity Troponin T Levels Following DC Cardioversion for Atrial Fibrillation Atrial Flutter
Sponsor:
University of Limerick
Organization:
University of Limerick
Study Overview
Official Title:
High Sensitivity Troponin T Levels Following Elective External Direct Current Cardioversion for Atrial Fibrillation Atrial Flutter
Status:
COMPLETED
Status Verified Date:
2015-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if there is a rise in serum high sensitivity troponin T a marker for heart muscle injury following a direct current cardioversion shock therapy used for patients with atrial fibrillation This will help us determine if direct current cardioversion results in damage to the heart muscles in a sufficient amount to cause a rise in high sensitivity troponin T
Detailed Description:
High sensitivity Troponin T is a relatively new biomarker that is highly sensitive and specific for myocardial injury Its widespread use has helped in the determination and investigation for myocardial ischemia in patients Previous studies have shown a rise in creatine kinase CK and the more specific creatine kinase-MB isoenzyme CKMB after DC cardioversion Studies on the earlier generation troponin T found that the levels dont rise or rise only minimally after DC cardioversion The high sensitivity troponin T has never been studied in the setting of DC cardioversion
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None